Head and Neck Cancer Trial, Recruiting NCT06915038 Sponsor: Indiana University Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT06915038
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older at the time of signing consent
  • You are able to sign a consent form and authorize use of your health information
  • You are generally able to carry out daily activities, with little to no limitation from your condition (confirm with trial site for exact fitness level required)
  • Your cancer is located in the oropharynx (the back part of the throat, including the tonsils, base of the tongue, soft palate, or back/side walls of the throat)
  • Your cancer has been confirmed as squamous cell carcinoma (a specific type of cancer) by a tissue sample
  • A specific marker of HPV-related cancer (called ctHPVDNA) has been detected in your blood before treatment
  • Your tumor can likely be fully removed by surgery with clear (cancer-free) edges
  • Both smokers and non-smokers are welcome to apply
  • Your tumor is at an early to moderate stage (T1 or T2, or certain T3 tumors that are movable and do not affect the voice box)
  • Your lymph nodes in the neck are at stage N0, N1, or N2
  • If your neck lymph nodes are affected, they are movable on physical examination
  • Your tumor has tested positive for HPV (the human papillomavirus)
  • If your cancer's original location is unclear, you may still be included under certain conditions (confirm with trial site)

Who may not be able to join:

  • You have a serious medical condition that would make it unsafe for you to have general anesthesia for surgery
  • You have previously had radiation treatment to the head or neck, or had a head or neck cancer, within the last 3 years
  • Your cancer has spread to other parts of the body (distant metastasis)
  • You have more than one HPV-positive throat cancer at the same time
  • You have had another type of invasive cancer within the last 3 years — exceptions may apply for certain skin cancers, thyroid cancer, or if you are considered fully cured (confirm with trial site)
  • You are currently pregnant or breastfeeding
  • If you are a woman who could potentially become pregnant, you must have a negative pregnancy test on the day of surgery — unless you have had your uterus or both ovaries removed, or have not had a menstrual period naturally for at least 12 months in a row

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michael Sim, MD, Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Phone: 317-529-6883

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
11 June 2025
Est. completion
1 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Disease Free Survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov